CITI Program – Biomedical Research Practice Exam

In research involving children, particularly when assessing the level of risk, the role of the Institutional Review Board (IRB) is to evaluate whether the potential risks are justified by the anticipated benefits of the research. When the conclusion of the IRB's assessment indicates that there is "no more than minimal risk to the child," it recognizes that the risks associated with the research procedures are not greater than those ordinarily encountered in daily life or during routine physical or psychological examinations.

This determination is crucial, as it helps to ensure the safety and welfare of the child participants in the study. Minimal risk allows for the ethical conduct of research involving vulnerable populations like children, while still producing valuable data that can impact pediatric healthcare. It underscores the need for protective measures in research design and protocol, ensuring that any risks to child participants are thoughtfully considered and minimized. Such an assurance can encourage researchers to proceed with studies that can lead to significant advancements in understanding children's health and development, all while adhering to ethical standards in research.